Sarinnapha Vasunilashorn, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delirium | 25 | 2024 | 1608 | 5.100 |
Why?
|
| C-Reactive Protein | 11 | 2021 | 3766 | 1.540 |
Why?
|
| Apolipoproteins E | 5 | 2020 | 1438 | 1.390 |
Why?
|
| Postoperative Complications | 17 | 2023 | 15244 | 1.170 |
Why?
|
| Confusion | 2 | 2020 | 275 | 1.110 |
Why?
|
| Psychometrics | 4 | 2022 | 2999 | 0.850 |
Why?
|
| Indians, South American | 2 | 2011 | 36 | 0.780 |
Why?
|
| Geriatric Assessment | 3 | 2020 | 1369 | 0.750 |
Why?
|
| Mobility Limitation | 3 | 2014 | 405 | 0.680 |
Why?
|
| Taiwan | 7 | 2018 | 496 | 0.650 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 2414 | 0.640 |
Why?
|
| Severity of Illness Index | 8 | 2020 | 15530 | 0.610 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 365 | 0.590 |
Why?
|
| Inflammation | 8 | 2022 | 10578 | 0.590 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 245 | 0.570 |
Why?
|
| Stress, Psychological | 4 | 2014 | 4229 | 0.520 |
Why?
|
| Apolipoprotein E4 | 2 | 2020 | 667 | 0.520 |
Why?
|
| Apolipoprotein E2 | 1 | 2015 | 127 | 0.500 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1015 | 0.500 |
Why?
|
| Aged | 45 | 2024 | 162944 | 0.490 |
Why?
|
| Walking | 2 | 2013 | 1177 | 0.470 |
Why?
|
| Cytokines | 3 | 2019 | 7317 | 0.470 |
Why?
|
| Disability Evaluation | 2 | 2013 | 1827 | 0.470 |
Why?
|
| Proteomics | 5 | 2023 | 3618 | 0.470 |
Why?
|
| Widowhood | 1 | 2013 | 54 | 0.460 |
Why?
|
| Interview, Psychological | 1 | 2016 | 812 | 0.440 |
Why?
|
| Aged, 80 and over | 22 | 2022 | 57683 | 0.430 |
Why?
|
| Metabolism | 1 | 2014 | 193 | 0.420 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2020 | 6030 | 0.420 |
Why?
|
| Body Weight | 2 | 2013 | 4664 | 0.420 |
Why?
|
| Marriage | 1 | 2013 | 338 | 0.410 |
Why?
|
| Health Status | 3 | 2014 | 4030 | 0.410 |
Why?
|
| Nutrition Surveys | 4 | 2021 | 1656 | 0.400 |
Why?
|
| Anabolic Agents | 1 | 2014 | 247 | 0.390 |
Why?
|
| Parasitic Diseases | 1 | 2010 | 75 | 0.370 |
Why?
|
| Wisconsin | 3 | 2016 | 124 | 0.370 |
Why?
|
| Lipids | 3 | 2011 | 3302 | 0.360 |
Why?
|
| Aging | 6 | 2021 | 8626 | 0.330 |
Why?
|
| Life Change Events | 1 | 2014 | 937 | 0.330 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 7988 | 0.320 |
Why?
|
| Female | 48 | 2022 | 379592 | 0.310 |
Why?
|
| Telomere | 1 | 2014 | 909 | 0.310 |
Why?
|
| Interleukin-6 | 3 | 2022 | 3199 | 0.300 |
Why?
|
| Male | 44 | 2021 | 349538 | 0.290 |
Why?
|
| Perception | 1 | 2013 | 1188 | 0.290 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1402 | 0.270 |
Why?
|
| Disabled Persons | 2 | 2013 | 1209 | 0.270 |
Why?
|
| Prospective Studies | 13 | 2022 | 53187 | 0.270 |
Why?
|
| Longitudinal Studies | 9 | 2018 | 13921 | 0.260 |
Why?
|
| Body Mass Index | 5 | 2016 | 12695 | 0.260 |
Why?
|
| Humans | 59 | 2024 | 742088 | 0.260 |
Why?
|
| Mental Health | 2 | 2016 | 2997 | 0.250 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.250 |
Why?
|
| Health Status Indicators | 1 | 2010 | 968 | 0.240 |
Why?
|
| Morbidity | 1 | 2010 | 1767 | 0.240 |
Why?
|
| Postural Balance | 1 | 2009 | 620 | 0.240 |
Why?
|
| Health Surveys | 2 | 2011 | 4030 | 0.240 |
Why?
|
| Vision Disorders | 1 | 2011 | 1057 | 0.230 |
Why?
|
| Proteome | 3 | 2022 | 1790 | 0.220 |
Why?
|
| Depressive Disorder | 1 | 2016 | 3748 | 0.220 |
Why?
|
| Logistic Models | 7 | 2020 | 13403 | 0.220 |
Why?
|
| Orthopedic Procedures | 3 | 2022 | 1288 | 0.210 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 19862 | 0.210 |
Why?
|
| Communicable Diseases | 1 | 2011 | 878 | 0.210 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2011 | 807 | 0.210 |
Why?
|
| Sex Factors | 5 | 2016 | 10392 | 0.200 |
Why?
|
| Cyclophosphamide | 3 | 2011 | 2236 | 0.200 |
Why?
|
| Incidence | 6 | 2023 | 20928 | 0.200 |
Why?
|
| Least-Squares Analysis | 2 | 2013 | 379 | 0.200 |
Why?
|
| Bolivia | 2 | 2011 | 19 | 0.200 |
Why?
|
| Hospitalization | 2 | 2020 | 10232 | 0.190 |
Why?
|
| Odds Ratio | 4 | 2016 | 9846 | 0.190 |
Why?
|
| Osmolar Concentration | 1 | 2021 | 683 | 0.190 |
Why?
|
| Urine | 1 | 2021 | 370 | 0.180 |
Why?
|
| Risk Factors | 11 | 2023 | 72145 | 0.180 |
Why?
|
| Case-Control Studies | 7 | 2023 | 21719 | 0.180 |
Why?
|
| Italy | 2 | 2013 | 828 | 0.170 |
Why?
|
| Scleroderma, Diffuse | 2 | 2008 | 16 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17400 | 0.160 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 318 | 0.160 |
Why?
|
| Genotype | 4 | 2020 | 12946 | 0.160 |
Why?
|
| Mortality | 1 | 2010 | 2857 | 0.160 |
Why?
|
| Alleles | 3 | 2020 | 6931 | 0.160 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39004 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 313 | 0.150 |
Why?
|
| Albuminuria | 1 | 2021 | 683 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3862 | 0.150 |
Why?
|
| Cognitive Reserve | 1 | 2017 | 76 | 0.150 |
Why?
|
| Age Factors | 4 | 2016 | 18355 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2020 | 1653 | 0.140 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2015 | 32 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 7770 | 0.130 |
Why?
|
| Computational Biology | 2 | 2023 | 3518 | 0.120 |
Why?
|
| Respiratory Function Tests | 2 | 2013 | 1613 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2167 | 0.120 |
Why?
|
| Middle Aged | 15 | 2021 | 213127 | 0.110 |
Why?
|
| Diet | 1 | 2011 | 7923 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2017 | 23320 | 0.110 |
Why?
|
| ROC Curve | 1 | 2020 | 3528 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1331 | 0.100 |
Why?
|
| England | 1 | 2013 | 523 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2021 | 40450 | 0.100 |
Why?
|
| Antirheumatic Agents | 1 | 2011 | 1335 | 0.100 |
Why?
|
| Cultural Characteristics | 1 | 2013 | 262 | 0.100 |
Why?
|
| Health Behavior | 2 | 2013 | 2630 | 0.100 |
Why?
|
| Polymorphism, Genetic | 2 | 2013 | 4328 | 0.100 |
Why?
|
| Spouses | 1 | 2013 | 284 | 0.100 |
Why?
|
| Obesity | 1 | 2013 | 12705 | 0.090 |
Why?
|
| Geriatrics | 1 | 2015 | 396 | 0.090 |
Why?
|
| Body Weights and Measures | 1 | 2010 | 211 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2011 | 4147 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.090 |
Why?
|
| Scleroderma, Localized | 1 | 2009 | 79 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2699 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2013 | 1583 | 0.080 |
Why?
|
| Scleroderma, Limited | 1 | 2008 | 8 | 0.080 |
Why?
|
| Vision, Low | 1 | 2011 | 168 | 0.080 |
Why?
|
| Nursing Homes | 1 | 2016 | 1034 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 12242 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 6974 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 3937 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6294 | 0.080 |
Why?
|
| Sex Ratio | 1 | 2008 | 110 | 0.080 |
Why?
|
| Homocysteine | 1 | 2011 | 647 | 0.080 |
Why?
|
| Genomics | 1 | 2023 | 5692 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2009 | 623 | 0.080 |
Why?
|
| Occupations | 1 | 2009 | 517 | 0.070 |
Why?
|
| Prognosis | 3 | 2021 | 29010 | 0.070 |
Why?
|
| Blindness | 1 | 2011 | 615 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20086 | 0.070 |
Why?
|
| Risk | 2 | 2017 | 9679 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2013 | 8541 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2948 | 0.070 |
Why?
|
| Kidney | 1 | 2021 | 7167 | 0.070 |
Why?
|
| Educational Status | 1 | 2013 | 2533 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2011 | 986 | 0.070 |
Why?
|
| Time Factors | 3 | 2016 | 40054 | 0.060 |
Why?
|
| Prevalence | 3 | 2021 | 15194 | 0.060 |
Why?
|
| Exercise | 1 | 2021 | 5611 | 0.060 |
Why?
|
| Longevity | 1 | 2013 | 1069 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2010 | 691 | 0.060 |
Why?
|
| Demography | 1 | 2010 | 1650 | 0.060 |
Why?
|
| Linear Models | 1 | 2015 | 5948 | 0.060 |
Why?
|
| Cognition | 2 | 2020 | 6722 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2366 | 0.060 |
Why?
|
| Dementia | 2 | 2017 | 2501 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2010 | 2295 | 0.060 |
Why?
|
| Reward | 1 | 2011 | 940 | 0.060 |
Why?
|
| Arteries | 1 | 2009 | 1118 | 0.060 |
Why?
|
| Life Expectancy | 1 | 2011 | 1183 | 0.060 |
Why?
|
| Vital Capacity | 2 | 2011 | 922 | 0.060 |
Why?
|
| Adolescent | 5 | 2021 | 85649 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2009 | 770 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 13256 | 0.060 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2023 | 69 | 0.060 |
Why?
|
| Adult | 10 | 2021 | 213712 | 0.060 |
Why?
|
| Infant Mortality | 1 | 2008 | 754 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2970 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2015 | 3740 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1149 | 0.050 |
Why?
|
| United States | 4 | 2021 | 69693 | 0.050 |
Why?
|
| Weight Gain | 1 | 2013 | 2282 | 0.050 |
Why?
|
| tau Proteins | 2 | 2024 | 1860 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2008 | 580 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1887 | 0.050 |
Why?
|
| Cholesterol | 1 | 2011 | 2895 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2016 | 3111 | 0.050 |
Why?
|
| Life Style | 1 | 2013 | 3824 | 0.050 |
Why?
|
| Hypertension | 2 | 2013 | 8455 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5705 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 7716 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2011 | 2585 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 572 | 0.050 |
Why?
|
| Adiposity | 1 | 2009 | 1806 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3306 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 524 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12344 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 575 | 0.040 |
Why?
|
| Quality of Life | 2 | 2019 | 12730 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2013 | 4030 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2011 | 10248 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1884 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 971 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 13853 | 0.040 |
Why?
|
| Calcinosis | 1 | 2006 | 1497 | 0.040 |
Why?
|
| Decision Making | 1 | 2011 | 3869 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2022 | 1122 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2019 | 356 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14720 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2013 | 15108 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15056 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3099 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 9144 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 7733 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2203 | 0.030 |
Why?
|
| Calcium | 1 | 2006 | 5753 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 1576 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2011 | 12017 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 1467 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1895 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 972 | 0.030 |
Why?
|
| Games, Experimental | 1 | 2011 | 32 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15494 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 3574 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 168561 | 0.020 |
Why?
|
| Executive Function | 1 | 2018 | 1362 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 24913 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77098 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2008 | 87 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 2008 | 143 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 40955 | 0.020 |
Why?
|
| Vitamin D | 1 | 2021 | 3211 | 0.020 |
Why?
|
| Pressure | 1 | 2011 | 1203 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2011 | 774 | 0.020 |
Why?
|
| Caregivers | 1 | 2019 | 2074 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2195 | 0.020 |
Why?
|
| Saliva | 1 | 2011 | 805 | 0.020 |
Why?
|
| Catecholamines | 1 | 2008 | 387 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6454 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8662 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2008 | 235 | 0.020 |
Why?
|
| Arabinose | 1 | 2005 | 31 | 0.020 |
Why?
|
| Yersinia pestis | 1 | 2005 | 33 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2005 | 102 | 0.020 |
Why?
|
| Spirometry | 1 | 2008 | 862 | 0.020 |
Why?
|
| Placebos | 1 | 2009 | 1677 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10372 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 21596 | 0.020 |
Why?
|
| Brain | 1 | 2011 | 26343 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6259 | 0.020 |
Why?
|
| Etoposide | 1 | 2005 | 637 | 0.010 |
Why?
|
| Catalysis | 1 | 2005 | 760 | 0.010 |
Why?
|
| Tryptophan | 1 | 2005 | 478 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2011 | 1825 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1265 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1801 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 936 | 0.010 |
Why?
|
| Child | 1 | 2011 | 77478 | 0.010 |
Why?
|
| Magnesium | 1 | 2005 | 813 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 1723 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 1263 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2633 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56350 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 2305 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 62966 | 0.010 |
Why?
|
| Oxygen | 1 | 2011 | 4169 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3847 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 35342 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 7010 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 6115 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4353 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6608 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6669 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5454 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8925 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13814 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2005 | 4214 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 9387 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 18112 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 7289 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 25575 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 35070 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 29717 | 0.000 |
Why?
|